Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Benton Jones Insider Profile
4 Followers
William Benton Jones, SVP, Pharmaceutical Development at Corvus Pharmaceuticals, holds 153.77K shares in Corvus Pharmaceuticals (Ticker: CRVS). Most recently, William Benton Jones Bought $20,000 shares of Corvus Pharmaceuticals on May 07, 2024 for an estimated value of 34.60K.
William Benton Jones Corvus Pharmaceuticals (CRVS)SVP, Pharmaceutical Development
Corvus Pharmaceuticals (CRVS)
SVP, Pharmaceutical Development
Ranked #28,660 out of 97,944 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+54.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of William Benton Jones's holdings
Insider Roles
SVP, Pharmaceutical Development
Roles that William Benton Jones holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 20, 2022 - Dec 20, 2023
Return:+100.00%
The most profitable trade made by William Benton Jones
William Benton Jones's Trading History
List of latest transactions for each holding click on a transaction to see William Benton Jones's performance on stock
You May Also Like
William Benton Jones insider profile FAQ
What is the percentage of profitable transactions made by William Benton Jones?
The percentage of profitable transactions made by William Benton Jones is 100%.
What is the average return per transaction made by William Benton Jones?
The average return per transaction made by William Benton Jones is 54.10%.
What stocks does William Benton Jones hold?
William Benton Jones holds: CRVS stocks.
What was William Benton Jones’s latest transaction?
William Benton Jones latest transaction was an Informative Buy of $34.60K.
What was William Benton Jones's most profitable transaction?
William Benton Jones’s most profitable transaction was an Informative Buy of CRVS stock on December 20, 2022. The return on the trade was 100.00%.
What is William Benton Jones's role in Corvus Pharmaceuticals?
William Benton Jones's role in Corvus Pharmaceuticals is SVP, Pharmaceutical Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.